Pharma & Healthcare
Global Polymyxin B for Injection Market Research Report 2025
- Sep 24, 25
- ID: 520693
- Pages: 84
- Figures: 87
- Views: 10
Report Scope
This report aims to provide a comprehensive presentation of the global market for Polymyxin B for Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Polymyxin B for Injection.
The Polymyxin B for Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Polymyxin B for Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Polymyxin B for Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Xellia
Fresenius Kabi
Shanghai Pharmaceuticals
Eugia
Gland Pharma
Soigner Pharma
Incepta Pharmaceuticals
Taj Pharmaceuticals
Segment by Type
50,000 Units
Others
Segment by Application
Hospital
Clinics
Other
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Polymyxin B for Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Polymyxin B for Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
This report aims to provide a comprehensive presentation of the global market for Polymyxin B for Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Polymyxin B for Injection.
The Polymyxin B for Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Polymyxin B for Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Polymyxin B for Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Xellia
Fresenius Kabi
Shanghai Pharmaceuticals
Eugia
Gland Pharma
Soigner Pharma
Incepta Pharmaceuticals
Taj Pharmaceuticals
Segment by Type
50,000 Units
Others
Segment by Application
Hospital
Clinics
Other
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Polymyxin B for Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Polymyxin B for Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Polymyxin B for Injection Market Overview
1.1 Product Definition
1.2 Polymyxin B for Injection by Type
1.2.1 Global Polymyxin B for Injection Market Value Comparison by Type (2024 VS 2031)
1.2.2 50,000 Units
1.2.3 Others
1.3 Polymyxin B for Injection by Application
1.3.1 Global Polymyxin B for Injection Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Clinics
1.3.4 Other
1.4 Global Polymyxin B for Injection Market Size Estimates and Forecasts
1.4.1 Global Polymyxin B for Injection Revenue 2020-2031
1.4.2 Global Polymyxin B for Injection Sales 2020-2031
1.4.3 Global Polymyxin B for Injection Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Polymyxin B for Injection Market Competition by Manufacturers
2.1 Global Polymyxin B for Injection Sales Market Share by Manufacturers (2020-2025)
2.2 Global Polymyxin B for Injection Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Polymyxin B for Injection Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Polymyxin B for Injection, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Polymyxin B for Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Polymyxin B for Injection, Product Type & Application
2.7 Global Key Manufacturers of Polymyxin B for Injection, Date of Enter into This Industry
2.8 Global Polymyxin B for Injection Market Competitive Situation and Trends
2.8.1 Global Polymyxin B for Injection Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Polymyxin B for Injection Players Market Share by Revenue
2.8.3 Global Polymyxin B for Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Polymyxin B for Injection Market Scenario by Region
3.1 Global Polymyxin B for Injection Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Polymyxin B for Injection Sales by Region: 2020-2031
3.2.1 Global Polymyxin B for Injection Sales by Region: 2020-2025
3.2.2 Global Polymyxin B for Injection Sales by Region: 2026-2031
3.3 Global Polymyxin B for Injection Revenue by Region: 2020-2031
3.3.1 Global Polymyxin B for Injection Revenue by Region: 2020-2025
3.3.2 Global Polymyxin B for Injection Revenue by Region: 2026-2031
3.4 North America Polymyxin B for Injection Market Facts & Figures by Country
3.4.1 North America Polymyxin B for Injection Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Polymyxin B for Injection Sales by Country (2020-2031)
3.4.3 North America Polymyxin B for Injection Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Polymyxin B for Injection Market Facts & Figures by Country
3.5.1 Europe Polymyxin B for Injection Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Polymyxin B for Injection Sales by Country (2020-2031)
3.5.3 Europe Polymyxin B for Injection Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Polymyxin B for Injection Market Facts & Figures by Region
3.6.1 Asia Pacific Polymyxin B for Injection Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Polymyxin B for Injection Sales by Region (2020-2031)
3.6.3 Asia Pacific Polymyxin B for Injection Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Polymyxin B for Injection Market Facts & Figures by Country
3.7.1 Latin America Polymyxin B for Injection Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Polymyxin B for Injection Sales by Country (2020-2031)
3.7.3 Latin America Polymyxin B for Injection Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Polymyxin B for Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Polymyxin B for Injection Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Polymyxin B for Injection Sales by Country (2020-2031)
3.8.3 Middle East and Africa Polymyxin B for Injection Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Polymyxin B for Injection Sales by Type (2020-2031)
4.1.1 Global Polymyxin B for Injection Sales by Type (2020-2025)
4.1.2 Global Polymyxin B for Injection Sales by Type (2026-2031)
4.1.3 Global Polymyxin B for Injection Sales Market Share by Type (2020-2031)
4.2 Global Polymyxin B for Injection Revenue by Type (2020-2031)
4.2.1 Global Polymyxin B for Injection Revenue by Type (2020-2025)
4.2.2 Global Polymyxin B for Injection Revenue by Type (2026-2031)
4.2.3 Global Polymyxin B for Injection Revenue Market Share by Type (2020-2031)
4.3 Global Polymyxin B for Injection Price by Type (2020-2031)
5 Segment by Application
5.1 Global Polymyxin B for Injection Sales by Application (2020-2031)
5.1.1 Global Polymyxin B for Injection Sales by Application (2020-2025)
5.1.2 Global Polymyxin B for Injection Sales by Application (2026-2031)
5.1.3 Global Polymyxin B for Injection Sales Market Share by Application (2020-2031)
5.2 Global Polymyxin B for Injection Revenue by Application (2020-2031)
5.2.1 Global Polymyxin B for Injection Revenue by Application (2020-2025)
5.2.2 Global Polymyxin B for Injection Revenue by Application (2026-2031)
5.2.3 Global Polymyxin B for Injection Revenue Market Share by Application (2020-2031)
5.3 Global Polymyxin B for Injection Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Xellia
6.1.1 Xellia Company Information
6.1.2 Xellia Description and Business Overview
6.1.3 Xellia Polymyxin B for Injection Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Xellia Polymyxin B for Injection Product Portfolio
6.1.5 Xellia Recent Developments/Updates
6.2 Fresenius Kabi
6.2.1 Fresenius Kabi Company Information
6.2.2 Fresenius Kabi Description and Business Overview
6.2.3 Fresenius Kabi Polymyxin B for Injection Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Fresenius Kabi Polymyxin B for Injection Product Portfolio
6.2.5 Fresenius Kabi Recent Developments/Updates
6.3 Shanghai Pharmaceuticals
6.3.1 Shanghai Pharmaceuticals Company Information
6.3.2 Shanghai Pharmaceuticals Description and Business Overview
6.3.3 Shanghai Pharmaceuticals Polymyxin B for Injection Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Shanghai Pharmaceuticals Polymyxin B for Injection Product Portfolio
6.3.5 Shanghai Pharmaceuticals Recent Developments/Updates
6.4 Eugia
6.4.1 Eugia Company Information
6.4.2 Eugia Description and Business Overview
6.4.3 Eugia Polymyxin B for Injection Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Eugia Polymyxin B for Injection Product Portfolio
6.4.5 Eugia Recent Developments/Updates
6.5 Gland Pharma
6.5.1 Gland Pharma Company Information
6.5.2 Gland Pharma Description and Business Overview
6.5.3 Gland Pharma Polymyxin B for Injection Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Gland Pharma Polymyxin B for Injection Product Portfolio
6.5.5 Gland Pharma Recent Developments/Updates
6.6 Soigner Pharma
6.6.1 Soigner Pharma Company Information
6.6.2 Soigner Pharma Description and Business Overview
6.6.3 Soigner Pharma Polymyxin B for Injection Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Soigner Pharma Polymyxin B for Injection Product Portfolio
6.6.5 Soigner Pharma Recent Developments/Updates
6.7 Incepta Pharmaceuticals
6.7.1 Incepta Pharmaceuticals Company Information
6.7.2 Incepta Pharmaceuticals Description and Business Overview
6.7.3 Incepta Pharmaceuticals Polymyxin B for Injection Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Incepta Pharmaceuticals Polymyxin B for Injection Product Portfolio
6.7.5 Incepta Pharmaceuticals Recent Developments/Updates
6.8 Taj Pharmaceuticals
6.8.1 Taj Pharmaceuticals Company Information
6.8.2 Taj Pharmaceuticals Description and Business Overview
6.8.3 Taj Pharmaceuticals Polymyxin B for Injection Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Taj Pharmaceuticals Polymyxin B for Injection Product Portfolio
6.8.5 Taj Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Polymyxin B for Injection Industry Chain Analysis
7.2 Polymyxin B for Injection Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Polymyxin B for Injection Production Mode & Process Analysis
7.4 Polymyxin B for Injection Sales and Marketing
7.4.1 Polymyxin B for Injection Sales Channels
7.4.2 Polymyxin B for Injection Distributors
7.5 Polymyxin B for Injection Customer Analysis
8 Polymyxin B for Injection Market Dynamics
8.1 Polymyxin B for Injection Industry Trends
8.2 Polymyxin B for Injection Market Drivers
8.3 Polymyxin B for Injection Market Challenges
8.4 Polymyxin B for Injection Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 Polymyxin B for Injection by Type
1.2.1 Global Polymyxin B for Injection Market Value Comparison by Type (2024 VS 2031)
1.2.2 50,000 Units
1.2.3 Others
1.3 Polymyxin B for Injection by Application
1.3.1 Global Polymyxin B for Injection Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Clinics
1.3.4 Other
1.4 Global Polymyxin B for Injection Market Size Estimates and Forecasts
1.4.1 Global Polymyxin B for Injection Revenue 2020-2031
1.4.2 Global Polymyxin B for Injection Sales 2020-2031
1.4.3 Global Polymyxin B for Injection Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Polymyxin B for Injection Market Competition by Manufacturers
2.1 Global Polymyxin B for Injection Sales Market Share by Manufacturers (2020-2025)
2.2 Global Polymyxin B for Injection Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Polymyxin B for Injection Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Polymyxin B for Injection, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Polymyxin B for Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Polymyxin B for Injection, Product Type & Application
2.7 Global Key Manufacturers of Polymyxin B for Injection, Date of Enter into This Industry
2.8 Global Polymyxin B for Injection Market Competitive Situation and Trends
2.8.1 Global Polymyxin B for Injection Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Polymyxin B for Injection Players Market Share by Revenue
2.8.3 Global Polymyxin B for Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Polymyxin B for Injection Market Scenario by Region
3.1 Global Polymyxin B for Injection Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Polymyxin B for Injection Sales by Region: 2020-2031
3.2.1 Global Polymyxin B for Injection Sales by Region: 2020-2025
3.2.2 Global Polymyxin B for Injection Sales by Region: 2026-2031
3.3 Global Polymyxin B for Injection Revenue by Region: 2020-2031
3.3.1 Global Polymyxin B for Injection Revenue by Region: 2020-2025
3.3.2 Global Polymyxin B for Injection Revenue by Region: 2026-2031
3.4 North America Polymyxin B for Injection Market Facts & Figures by Country
3.4.1 North America Polymyxin B for Injection Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Polymyxin B for Injection Sales by Country (2020-2031)
3.4.3 North America Polymyxin B for Injection Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Polymyxin B for Injection Market Facts & Figures by Country
3.5.1 Europe Polymyxin B for Injection Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Polymyxin B for Injection Sales by Country (2020-2031)
3.5.3 Europe Polymyxin B for Injection Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Polymyxin B for Injection Market Facts & Figures by Region
3.6.1 Asia Pacific Polymyxin B for Injection Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Polymyxin B for Injection Sales by Region (2020-2031)
3.6.3 Asia Pacific Polymyxin B for Injection Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Polymyxin B for Injection Market Facts & Figures by Country
3.7.1 Latin America Polymyxin B for Injection Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Polymyxin B for Injection Sales by Country (2020-2031)
3.7.3 Latin America Polymyxin B for Injection Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Polymyxin B for Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Polymyxin B for Injection Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Polymyxin B for Injection Sales by Country (2020-2031)
3.8.3 Middle East and Africa Polymyxin B for Injection Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Polymyxin B for Injection Sales by Type (2020-2031)
4.1.1 Global Polymyxin B for Injection Sales by Type (2020-2025)
4.1.2 Global Polymyxin B for Injection Sales by Type (2026-2031)
4.1.3 Global Polymyxin B for Injection Sales Market Share by Type (2020-2031)
4.2 Global Polymyxin B for Injection Revenue by Type (2020-2031)
4.2.1 Global Polymyxin B for Injection Revenue by Type (2020-2025)
4.2.2 Global Polymyxin B for Injection Revenue by Type (2026-2031)
4.2.3 Global Polymyxin B for Injection Revenue Market Share by Type (2020-2031)
4.3 Global Polymyxin B for Injection Price by Type (2020-2031)
5 Segment by Application
5.1 Global Polymyxin B for Injection Sales by Application (2020-2031)
5.1.1 Global Polymyxin B for Injection Sales by Application (2020-2025)
5.1.2 Global Polymyxin B for Injection Sales by Application (2026-2031)
5.1.3 Global Polymyxin B for Injection Sales Market Share by Application (2020-2031)
5.2 Global Polymyxin B for Injection Revenue by Application (2020-2031)
5.2.1 Global Polymyxin B for Injection Revenue by Application (2020-2025)
5.2.2 Global Polymyxin B for Injection Revenue by Application (2026-2031)
5.2.3 Global Polymyxin B for Injection Revenue Market Share by Application (2020-2031)
5.3 Global Polymyxin B for Injection Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Xellia
6.1.1 Xellia Company Information
6.1.2 Xellia Description and Business Overview
6.1.3 Xellia Polymyxin B for Injection Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Xellia Polymyxin B for Injection Product Portfolio
6.1.5 Xellia Recent Developments/Updates
6.2 Fresenius Kabi
6.2.1 Fresenius Kabi Company Information
6.2.2 Fresenius Kabi Description and Business Overview
6.2.3 Fresenius Kabi Polymyxin B for Injection Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Fresenius Kabi Polymyxin B for Injection Product Portfolio
6.2.5 Fresenius Kabi Recent Developments/Updates
6.3 Shanghai Pharmaceuticals
6.3.1 Shanghai Pharmaceuticals Company Information
6.3.2 Shanghai Pharmaceuticals Description and Business Overview
6.3.3 Shanghai Pharmaceuticals Polymyxin B for Injection Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Shanghai Pharmaceuticals Polymyxin B for Injection Product Portfolio
6.3.5 Shanghai Pharmaceuticals Recent Developments/Updates
6.4 Eugia
6.4.1 Eugia Company Information
6.4.2 Eugia Description and Business Overview
6.4.3 Eugia Polymyxin B for Injection Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Eugia Polymyxin B for Injection Product Portfolio
6.4.5 Eugia Recent Developments/Updates
6.5 Gland Pharma
6.5.1 Gland Pharma Company Information
6.5.2 Gland Pharma Description and Business Overview
6.5.3 Gland Pharma Polymyxin B for Injection Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Gland Pharma Polymyxin B for Injection Product Portfolio
6.5.5 Gland Pharma Recent Developments/Updates
6.6 Soigner Pharma
6.6.1 Soigner Pharma Company Information
6.6.2 Soigner Pharma Description and Business Overview
6.6.3 Soigner Pharma Polymyxin B for Injection Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Soigner Pharma Polymyxin B for Injection Product Portfolio
6.6.5 Soigner Pharma Recent Developments/Updates
6.7 Incepta Pharmaceuticals
6.7.1 Incepta Pharmaceuticals Company Information
6.7.2 Incepta Pharmaceuticals Description and Business Overview
6.7.3 Incepta Pharmaceuticals Polymyxin B for Injection Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Incepta Pharmaceuticals Polymyxin B for Injection Product Portfolio
6.7.5 Incepta Pharmaceuticals Recent Developments/Updates
6.8 Taj Pharmaceuticals
6.8.1 Taj Pharmaceuticals Company Information
6.8.2 Taj Pharmaceuticals Description and Business Overview
6.8.3 Taj Pharmaceuticals Polymyxin B for Injection Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Taj Pharmaceuticals Polymyxin B for Injection Product Portfolio
6.8.5 Taj Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Polymyxin B for Injection Industry Chain Analysis
7.2 Polymyxin B for Injection Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Polymyxin B for Injection Production Mode & Process Analysis
7.4 Polymyxin B for Injection Sales and Marketing
7.4.1 Polymyxin B for Injection Sales Channels
7.4.2 Polymyxin B for Injection Distributors
7.5 Polymyxin B for Injection Customer Analysis
8 Polymyxin B for Injection Market Dynamics
8.1 Polymyxin B for Injection Industry Trends
8.2 Polymyxin B for Injection Market Drivers
8.3 Polymyxin B for Injection Market Challenges
8.4 Polymyxin B for Injection Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Polymyxin B for Injection Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Polymyxin B for Injection Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Polymyxin B for Injection Market Competitive Situation by Manufacturers in 2024
Table 4. Global Polymyxin B for Injection Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Polymyxin B for Injection Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Polymyxin B for Injection Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Polymyxin B for Injection Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Polymyxin B for Injection Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Polymyxin B for Injection, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Polymyxin B for Injection, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Polymyxin B for Injection, Product Type & Application
Table 12. Global Key Manufacturers of Polymyxin B for Injection, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Polymyxin B for Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Polymyxin B for Injection as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Polymyxin B for Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Polymyxin B for Injection Sales by Region (2020-2025) & (K Units)
Table 18. Global Polymyxin B for Injection Sales Market Share by Region (2020-2025)
Table 19. Global Polymyxin B for Injection Sales by Region (2026-2031) & (K Units)
Table 20. Global Polymyxin B for Injection Sales Market Share by Region (2026-2031)
Table 21. Global Polymyxin B for Injection Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Polymyxin B for Injection Revenue Market Share by Region (2020-2025)
Table 23. Global Polymyxin B for Injection Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Polymyxin B for Injection Revenue Market Share by Region (2026-2031)
Table 25. North America Polymyxin B for Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Polymyxin B for Injection Sales by Country (2020-2025) & (K Units)
Table 27. North America Polymyxin B for Injection Sales by Country (2026-2031) & (K Units)
Table 28. North America Polymyxin B for Injection Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Polymyxin B for Injection Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Polymyxin B for Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Polymyxin B for Injection Sales by Country (2020-2025) & (K Units)
Table 32. Europe Polymyxin B for Injection Sales by Country (2026-2031) & (K Units)
Table 33. Europe Polymyxin B for Injection Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Polymyxin B for Injection Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Polymyxin B for Injection Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Polymyxin B for Injection Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Polymyxin B for Injection Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Polymyxin B for Injection Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Polymyxin B for Injection Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Polymyxin B for Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Polymyxin B for Injection Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Polymyxin B for Injection Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Polymyxin B for Injection Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Polymyxin B for Injection Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Polymyxin B for Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Polymyxin B for Injection Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Polymyxin B for Injection Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Polymyxin B for Injection Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Polymyxin B for Injection Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Polymyxin B for Injection Sales (K Units) by Type (2020-2025)
Table 51. Global Polymyxin B for Injection Sales (K Units) by Type (2026-2031)
Table 52. Global Polymyxin B for Injection Sales Market Share by Type (2020-2025)
Table 53. Global Polymyxin B for Injection Sales Market Share by Type (2026-2031)
Table 54. Global Polymyxin B for Injection Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Polymyxin B for Injection Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Polymyxin B for Injection Revenue Market Share by Type (2020-2025)
Table 57. Global Polymyxin B for Injection Revenue Market Share by Type (2026-2031)
Table 58. Global Polymyxin B for Injection Price (US$/Unit) by Type (2020-2025)
Table 59. Global Polymyxin B for Injection Price (US$/Unit) by Type (2026-2031)
Table 60. Global Polymyxin B for Injection Sales (K Units) by Application (2020-2025)
Table 61. Global Polymyxin B for Injection Sales (K Units) by Application (2026-2031)
Table 62. Global Polymyxin B for Injection Sales Market Share by Application (2020-2025)
Table 63. Global Polymyxin B for Injection Sales Market Share by Application (2026-2031)
Table 64. Global Polymyxin B for Injection Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Polymyxin B for Injection Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Polymyxin B for Injection Revenue Market Share by Application (2020-2025)
Table 67. Global Polymyxin B for Injection Revenue Market Share by Application (2026-2031)
Table 68. Global Polymyxin B for Injection Price (US$/Unit) by Application (2020-2025)
Table 69. Global Polymyxin B for Injection Price (US$/Unit) by Application (2026-2031)
Table 70. Xellia Company Information
Table 71. Xellia Description and Business Overview
Table 72. Xellia Polymyxin B for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Xellia Polymyxin B for Injection Product
Table 74. Xellia Recent Developments/Updates
Table 75. Fresenius Kabi Company Information
Table 76. Fresenius Kabi Description and Business Overview
Table 77. Fresenius Kabi Polymyxin B for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Fresenius Kabi Polymyxin B for Injection Product
Table 79. Fresenius Kabi Recent Developments/Updates
Table 80. Shanghai Pharmaceuticals Company Information
Table 81. Shanghai Pharmaceuticals Description and Business Overview
Table 82. Shanghai Pharmaceuticals Polymyxin B for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Shanghai Pharmaceuticals Polymyxin B for Injection Product
Table 84. Shanghai Pharmaceuticals Recent Developments/Updates
Table 85. Eugia Company Information
Table 86. Eugia Description and Business Overview
Table 87. Eugia Polymyxin B for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Eugia Polymyxin B for Injection Product
Table 89. Eugia Recent Developments/Updates
Table 90. Gland Pharma Company Information
Table 91. Gland Pharma Description and Business Overview
Table 92. Gland Pharma Polymyxin B for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Gland Pharma Polymyxin B for Injection Product
Table 94. Gland Pharma Recent Developments/Updates
Table 95. Soigner Pharma Company Information
Table 96. Soigner Pharma Description and Business Overview
Table 97. Soigner Pharma Polymyxin B for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Soigner Pharma Polymyxin B for Injection Product
Table 99. Soigner Pharma Recent Developments/Updates
Table 100. Incepta Pharmaceuticals Company Information
Table 101. Incepta Pharmaceuticals Description and Business Overview
Table 102. Incepta Pharmaceuticals Polymyxin B for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Incepta Pharmaceuticals Polymyxin B for Injection Product
Table 104. Incepta Pharmaceuticals Recent Developments/Updates
Table 105. Taj Pharmaceuticals Company Information
Table 106. Taj Pharmaceuticals Description and Business Overview
Table 107. Taj Pharmaceuticals Polymyxin B for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Taj Pharmaceuticals Polymyxin B for Injection Product
Table 109. Taj Pharmaceuticals Recent Developments/Updates
Table 110. Key Raw Materials Lists
Table 111. Raw Materials Key Suppliers Lists
Table 112. Polymyxin B for Injection Distributors List
Table 113. Polymyxin B for Injection Customers List
Table 114. Polymyxin B for Injection Market Trends
Table 115. Polymyxin B for Injection Market Drivers
Table 116. Polymyxin B for Injection Market Challenges
Table 117. Polymyxin B for Injection Market Restraints
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
Table 121. Authors List of This Report
List of Figures
Figure 1. Product Picture of Polymyxin B for Injection
Figure 2. Global Polymyxin B for Injection Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Polymyxin B for Injection Market Share by Type: 2024 & 2031
Figure 4. 50,000 Units Product Picture
Figure 5. Others Product Picture
Figure 6. Global Polymyxin B for Injection Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Polymyxin B for Injection Market Share by Application: 2024 & 2031
Figure 8. Hospital
Figure 9. Clinics
Figure 10. Other
Figure 11. Global Polymyxin B for Injection Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Polymyxin B for Injection Market Size (2020-2031) & (US$ Million)
Figure 13. Global Polymyxin B for Injection Sales (2020-2031) & (K Units)
Figure 14. Global Polymyxin B for Injection Average Price (US$/Unit) & (2020-2031)
Figure 15. Polymyxin B for Injection Report Years Considered
Figure 16. Polymyxin B for Injection Sales Share by Manufacturers in 2024
Figure 17. Global Polymyxin B for Injection Revenue Share by Manufacturers in 2024
Figure 18. Global 5 and 10 Largest Polymyxin B for Injection Players: Market Share by Revenue in Polymyxin B for Injection in 2024
Figure 19. Polymyxin B for Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 20. Global Polymyxin B for Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 21. North America Polymyxin B for Injection Sales Market Share by Country (2020-2031)
Figure 22. North America Polymyxin B for Injection Revenue Market Share by Country (2020-2031)
Figure 23. United States Polymyxin B for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Canada Polymyxin B for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Europe Polymyxin B for Injection Sales Market Share by Country (2020-2031)
Figure 26. Europe Polymyxin B for Injection Revenue Market Share by Country (2020-2031)
Figure 27. Germany Polymyxin B for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. France Polymyxin B for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. U.K. Polymyxin B for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Italy Polymyxin B for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Russia Polymyxin B for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Asia Pacific Polymyxin B for Injection Sales Market Share by Region (2020-2031)
Figure 33. Asia Pacific Polymyxin B for Injection Revenue Market Share by Region (2020-2031)
Figure 34. China Polymyxin B for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Japan Polymyxin B for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. South Korea Polymyxin B for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. India Polymyxin B for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Australia Polymyxin B for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. China Taiwan Polymyxin B for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Southeast Asia Polymyxin B for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Latin America Polymyxin B for Injection Sales Market Share by Country (2020-2031)
Figure 42. Latin America Polymyxin B for Injection Revenue Market Share by Country (2020-2031)
Figure 43. Mexico Polymyxin B for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Brazil Polymyxin B for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Argentina Polymyxin B for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Middle East and Africa Polymyxin B for Injection Sales Market Share by Country (2020-2031)
Figure 47. Middle East and Africa Polymyxin B for Injection Revenue Market Share by Country (2020-2031)
Figure 48. Turkey Polymyxin B for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Saudi Arabia Polymyxin B for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. UAE Polymyxin B for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Global Sales Market Share of Polymyxin B for Injection by Type (2020-2031)
Figure 52. Global Revenue Market Share of Polymyxin B for Injection by Type (2020-2031)
Figure 53. Global Polymyxin B for Injection Price (US$/Unit) by Type (2020-2031)
Figure 54. Global Sales Market Share of Polymyxin B for Injection by Application (2020-2031)
Figure 55. Global Revenue Market Share of Polymyxin B for Injection by Application (2020-2031)
Figure 56. Global Polymyxin B for Injection Price (US$/Unit) by Application (2020-2031)
Figure 57. Polymyxin B for Injection Value Chain
Figure 58. Channels of Distribution (Direct Vs Distribution)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Table 1. Global Polymyxin B for Injection Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Polymyxin B for Injection Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Polymyxin B for Injection Market Competitive Situation by Manufacturers in 2024
Table 4. Global Polymyxin B for Injection Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Polymyxin B for Injection Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Polymyxin B for Injection Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Polymyxin B for Injection Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Polymyxin B for Injection Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Polymyxin B for Injection, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Polymyxin B for Injection, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Polymyxin B for Injection, Product Type & Application
Table 12. Global Key Manufacturers of Polymyxin B for Injection, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Polymyxin B for Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Polymyxin B for Injection as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Polymyxin B for Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Polymyxin B for Injection Sales by Region (2020-2025) & (K Units)
Table 18. Global Polymyxin B for Injection Sales Market Share by Region (2020-2025)
Table 19. Global Polymyxin B for Injection Sales by Region (2026-2031) & (K Units)
Table 20. Global Polymyxin B for Injection Sales Market Share by Region (2026-2031)
Table 21. Global Polymyxin B for Injection Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Polymyxin B for Injection Revenue Market Share by Region (2020-2025)
Table 23. Global Polymyxin B for Injection Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Polymyxin B for Injection Revenue Market Share by Region (2026-2031)
Table 25. North America Polymyxin B for Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Polymyxin B for Injection Sales by Country (2020-2025) & (K Units)
Table 27. North America Polymyxin B for Injection Sales by Country (2026-2031) & (K Units)
Table 28. North America Polymyxin B for Injection Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Polymyxin B for Injection Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Polymyxin B for Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Polymyxin B for Injection Sales by Country (2020-2025) & (K Units)
Table 32. Europe Polymyxin B for Injection Sales by Country (2026-2031) & (K Units)
Table 33. Europe Polymyxin B for Injection Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Polymyxin B for Injection Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Polymyxin B for Injection Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Polymyxin B for Injection Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Polymyxin B for Injection Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Polymyxin B for Injection Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Polymyxin B for Injection Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Polymyxin B for Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Polymyxin B for Injection Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Polymyxin B for Injection Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Polymyxin B for Injection Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Polymyxin B for Injection Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Polymyxin B for Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Polymyxin B for Injection Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Polymyxin B for Injection Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Polymyxin B for Injection Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Polymyxin B for Injection Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Polymyxin B for Injection Sales (K Units) by Type (2020-2025)
Table 51. Global Polymyxin B for Injection Sales (K Units) by Type (2026-2031)
Table 52. Global Polymyxin B for Injection Sales Market Share by Type (2020-2025)
Table 53. Global Polymyxin B for Injection Sales Market Share by Type (2026-2031)
Table 54. Global Polymyxin B for Injection Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Polymyxin B for Injection Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Polymyxin B for Injection Revenue Market Share by Type (2020-2025)
Table 57. Global Polymyxin B for Injection Revenue Market Share by Type (2026-2031)
Table 58. Global Polymyxin B for Injection Price (US$/Unit) by Type (2020-2025)
Table 59. Global Polymyxin B for Injection Price (US$/Unit) by Type (2026-2031)
Table 60. Global Polymyxin B for Injection Sales (K Units) by Application (2020-2025)
Table 61. Global Polymyxin B for Injection Sales (K Units) by Application (2026-2031)
Table 62. Global Polymyxin B for Injection Sales Market Share by Application (2020-2025)
Table 63. Global Polymyxin B for Injection Sales Market Share by Application (2026-2031)
Table 64. Global Polymyxin B for Injection Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Polymyxin B for Injection Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Polymyxin B for Injection Revenue Market Share by Application (2020-2025)
Table 67. Global Polymyxin B for Injection Revenue Market Share by Application (2026-2031)
Table 68. Global Polymyxin B for Injection Price (US$/Unit) by Application (2020-2025)
Table 69. Global Polymyxin B for Injection Price (US$/Unit) by Application (2026-2031)
Table 70. Xellia Company Information
Table 71. Xellia Description and Business Overview
Table 72. Xellia Polymyxin B for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Xellia Polymyxin B for Injection Product
Table 74. Xellia Recent Developments/Updates
Table 75. Fresenius Kabi Company Information
Table 76. Fresenius Kabi Description and Business Overview
Table 77. Fresenius Kabi Polymyxin B for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Fresenius Kabi Polymyxin B for Injection Product
Table 79. Fresenius Kabi Recent Developments/Updates
Table 80. Shanghai Pharmaceuticals Company Information
Table 81. Shanghai Pharmaceuticals Description and Business Overview
Table 82. Shanghai Pharmaceuticals Polymyxin B for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Shanghai Pharmaceuticals Polymyxin B for Injection Product
Table 84. Shanghai Pharmaceuticals Recent Developments/Updates
Table 85. Eugia Company Information
Table 86. Eugia Description and Business Overview
Table 87. Eugia Polymyxin B for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Eugia Polymyxin B for Injection Product
Table 89. Eugia Recent Developments/Updates
Table 90. Gland Pharma Company Information
Table 91. Gland Pharma Description and Business Overview
Table 92. Gland Pharma Polymyxin B for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Gland Pharma Polymyxin B for Injection Product
Table 94. Gland Pharma Recent Developments/Updates
Table 95. Soigner Pharma Company Information
Table 96. Soigner Pharma Description and Business Overview
Table 97. Soigner Pharma Polymyxin B for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Soigner Pharma Polymyxin B for Injection Product
Table 99. Soigner Pharma Recent Developments/Updates
Table 100. Incepta Pharmaceuticals Company Information
Table 101. Incepta Pharmaceuticals Description and Business Overview
Table 102. Incepta Pharmaceuticals Polymyxin B for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Incepta Pharmaceuticals Polymyxin B for Injection Product
Table 104. Incepta Pharmaceuticals Recent Developments/Updates
Table 105. Taj Pharmaceuticals Company Information
Table 106. Taj Pharmaceuticals Description and Business Overview
Table 107. Taj Pharmaceuticals Polymyxin B for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Taj Pharmaceuticals Polymyxin B for Injection Product
Table 109. Taj Pharmaceuticals Recent Developments/Updates
Table 110. Key Raw Materials Lists
Table 111. Raw Materials Key Suppliers Lists
Table 112. Polymyxin B for Injection Distributors List
Table 113. Polymyxin B for Injection Customers List
Table 114. Polymyxin B for Injection Market Trends
Table 115. Polymyxin B for Injection Market Drivers
Table 116. Polymyxin B for Injection Market Challenges
Table 117. Polymyxin B for Injection Market Restraints
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
Table 121. Authors List of This Report
List of Figures
Figure 1. Product Picture of Polymyxin B for Injection
Figure 2. Global Polymyxin B for Injection Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Polymyxin B for Injection Market Share by Type: 2024 & 2031
Figure 4. 50,000 Units Product Picture
Figure 5. Others Product Picture
Figure 6. Global Polymyxin B for Injection Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Polymyxin B for Injection Market Share by Application: 2024 & 2031
Figure 8. Hospital
Figure 9. Clinics
Figure 10. Other
Figure 11. Global Polymyxin B for Injection Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Polymyxin B for Injection Market Size (2020-2031) & (US$ Million)
Figure 13. Global Polymyxin B for Injection Sales (2020-2031) & (K Units)
Figure 14. Global Polymyxin B for Injection Average Price (US$/Unit) & (2020-2031)
Figure 15. Polymyxin B for Injection Report Years Considered
Figure 16. Polymyxin B for Injection Sales Share by Manufacturers in 2024
Figure 17. Global Polymyxin B for Injection Revenue Share by Manufacturers in 2024
Figure 18. Global 5 and 10 Largest Polymyxin B for Injection Players: Market Share by Revenue in Polymyxin B for Injection in 2024
Figure 19. Polymyxin B for Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 20. Global Polymyxin B for Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 21. North America Polymyxin B for Injection Sales Market Share by Country (2020-2031)
Figure 22. North America Polymyxin B for Injection Revenue Market Share by Country (2020-2031)
Figure 23. United States Polymyxin B for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Canada Polymyxin B for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Europe Polymyxin B for Injection Sales Market Share by Country (2020-2031)
Figure 26. Europe Polymyxin B for Injection Revenue Market Share by Country (2020-2031)
Figure 27. Germany Polymyxin B for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. France Polymyxin B for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. U.K. Polymyxin B for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Italy Polymyxin B for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Russia Polymyxin B for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Asia Pacific Polymyxin B for Injection Sales Market Share by Region (2020-2031)
Figure 33. Asia Pacific Polymyxin B for Injection Revenue Market Share by Region (2020-2031)
Figure 34. China Polymyxin B for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Japan Polymyxin B for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. South Korea Polymyxin B for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. India Polymyxin B for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Australia Polymyxin B for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. China Taiwan Polymyxin B for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Southeast Asia Polymyxin B for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Latin America Polymyxin B for Injection Sales Market Share by Country (2020-2031)
Figure 42. Latin America Polymyxin B for Injection Revenue Market Share by Country (2020-2031)
Figure 43. Mexico Polymyxin B for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Brazil Polymyxin B for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Argentina Polymyxin B for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Middle East and Africa Polymyxin B for Injection Sales Market Share by Country (2020-2031)
Figure 47. Middle East and Africa Polymyxin B for Injection Revenue Market Share by Country (2020-2031)
Figure 48. Turkey Polymyxin B for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Saudi Arabia Polymyxin B for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. UAE Polymyxin B for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Global Sales Market Share of Polymyxin B for Injection by Type (2020-2031)
Figure 52. Global Revenue Market Share of Polymyxin B for Injection by Type (2020-2031)
Figure 53. Global Polymyxin B for Injection Price (US$/Unit) by Type (2020-2031)
Figure 54. Global Sales Market Share of Polymyxin B for Injection by Application (2020-2031)
Figure 55. Global Revenue Market Share of Polymyxin B for Injection by Application (2020-2031)
Figure 56. Global Polymyxin B for Injection Price (US$/Unit) by Application (2020-2031)
Figure 57. Polymyxin B for Injection Value Chain
Figure 58. Channels of Distribution (Direct Vs Distribution)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global LED Light Housing Market Research Report 2025
Sep 24, 25
Global Side Emitting LED Strip Light Market Research Report 2025
Sep 24, 25
Global Medium and Low Voltage Unshielded Cable Market Research Report 2025
Sep 24, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232